The market leads due to advanced healthcare infrastructure, strong reimbursement support, and high awareness of infection prevention. A large patient pool with urological conditions and rapid adoption of innovative, patient-friendly catheter technologies further drive market growth.
The U.S. hydrophilic catheters are medical catheters coated with a water-activated layer that becomes smooth and slippery when wet, reducing friction during insertion and removal. It is used for urinary drainage while improving comfort and lowering the risk of infection and urethral injury. The U.S. hydrophilic catheters market is growing due to the rising prevalence of urinary disorders, increasing aging population, and strong awareness of infection prevention. Advanced healthcare infrastructure and favorable reimbursement policies support widespread adoption. Additionally, growing preference for home healthcare, self-catheterization, and continuous innovation in catheter technologies further drive demand across clinical and personal care settings.
The global hydrophilic catheters market size was estimated at USD 2.41 billion in 2025 and is predicted to increase from USD 2.6 billion in 2026 to approximately USD 5.13 billion by 2035, expanding at a CAGR of 7.85% from 2026 to 2035
The U.S. hydrophilic catheters market is expected to grow steadily due to rising urological disorders, increasing adoption of home healthcare, and ongoing advancements in coating technologies. Growing aging populations and demand for safer, minimally invasive solutions will continue to drive long-term market expansion.
| Indicator | Data |
| Hospital patients using urinary catheters | 15-25% |
| UTIs linked to the use of catheters in hospitals | 75% |
| UTIs among healthcare-associated infections | 30% |
Government data shows a high burden of catheter-related infections, with most hospital UTIs linked to catheter use. This highlights the need for safer solutions like hydrophilic catheters, which help reduce friction and infection risk, improving overall patient outcomes.
The intermittent catheters segment held a dominant share of 58% in 2025 and is expected to grow at the fastest CAGR of 8.4% in the U.S. hydrophilic catheters market during the forecast period due to its lower risk of urinary tract infections compared to indwelling catheters and its suitability for repeated, short-term use. These catheters support self-catheterization, making them ideal for home care. Increasing prevalence of urinary disorders, improved patient comfort, and growing awareness about safer bladder management practices further contributed to their widespread adoption.
The fully hydrophilic coated segment held a dominant share of 52% in 2025 and is expected to grow at the fastest CAGR of 8.6% in the hydrophilic catheters market during the forecast period due to its superior lubrication, which minimizes friction and reduces urethral trauma during catheterization. These coatings also help lower infection risk, limiting bacterial adherence. Growing preference for comfortable, ready-to-use solutions, along with self-catheterization, further strengthened demand for fully hydrophilic coated catheters.
The urinary incontinence segment dominated the U.S. hydrophilic catheters market with a revenue share of 34% in 2025 due to its high global prevalence, particularly among the aging population and patients with neurological conditions. Increasing awareness, improved diagnosis rates, and rising demand for effective bladder management solutions drive catheter use. Additionally, the growing shift towards home healthcare and the availability of easy-to-use catheter products further support the segment’s leading position.
The hospitals segment led the U.S. hydrophilic catheters market with a share of 49% in 2025 due to the high volume of surgeries, emergency cases, and critical care procedures requiring catheterization. Hospitals remain primary centers for diagnosis and treatment, ensuring consistent usage. Availability of skilled professionals, advanced infrastructure, and strict infection control protocols further support demand, while increasing patient admission and complex procedures continue to strengthen the segment’s dominance.
Leading companies in the U.S. hydrophilic catheters market include Becton, Dickinson and Company, Teleflex Incorporated, Hollister Incorporated, and Boston Scientific Corporation. These players drive growth through advanced hydrophilic coating technologies, user-friendly catheter designs, and infection-prevention solutions. Continuous innovation in minimally invasive urology care, improved product safety, and expansion of home healthcare solutions further strengthen their presence across the U.S. healthcare system.
By Product Type
By Coating Type
By Material
By Indication
By End User
By Distribution Channel
